Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06934096 · ClinicalTrials.gov registry record · NA
Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.
A NA study, sponsored by Northwell Health.
- Not yet
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT06934096 is a NA study that has not yet begun recruiting, run by Northwell Health. The registered enrollment target is 39 participants.
The verdict
NCT06934096, a NA study, has not yet begun recruiting, sponsored by Northwell Health.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This is a three-cohort, randomized, double-blinded , sham-controlled, single-center, early feasibility research trial to determine whether organ-specific biologic effects on platelet activity and coagulation are achievable through selective ultrasound of the spleen utilizing low-energy (diagnostic-level) insonification. * Group 1: Focused insonification at center of the spleen. * Group 2: Prolonged duration insonification at center of the spleen * Group 3: Prolonged duration insonification across the spleen. Participants will receive 30 minutes of sham stimulation in the randomized group that is assigned to them, followed by active stimulation within the same group. Blood biomarkers (local and systemic) will be measured before and at several timepoints after stimulation to measure the molecular and cellular effects of the device
Interventions
- DEVICE Ultrasound Pulsed Doppler Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2026-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06934096
The ClinicalTrials.gov registry entry for NCT06934096 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ultrasound Pulsed Doppler Imaging System is the first listed.
NCT06934096 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06934096 about?
NCT06934096 is a clinical study titled "Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.". This is a three-cohort, randomized, double-blinded , sham-controlled, single-center, early feasibility research trial to determine whether organ-specific biologic effects on platelet activity and coagulation are achievable through selective ultrasound of the spleen utilizing low-energy (diagnostic-l...
What is the current status of trial NCT06934096?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 39 participants. The study started on 2025-04-15. Estimated completion is 2026-05-12.
What interventions are being tested in trial NCT06934096?
The interventions under investigation include: Ultrasound Pulsed Doppler Imaging System (DEVICE).
Who is sponsoring clinical trial NCT06934096?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.